
The Wildhearts frontman Ginger Wildheart shares “rare but aggressive” cancer diagnosis
Ginger Wildheart, frontman of Newcastle rock band The Wildhearts, has been diagnosed with a “rare but aggressive” form of cancer.
The band revealed the news in a social media post on March 16th, explaining that Wildheart had begun experiencing unexplained pain, which he nursed with painkillers during their most recent tour in December 2025, “to ensure that rock ‘n’ roll was delivered, without missing a riff”.
However, after seeking medical advice, the statement said: “The results have been confirmed and we are saddened to report that Ginger has been diagnosed with Mantle Cell Lymphoma (MCL) – a rare but aggressive strain of cancer.”
According to the NHS, Mantle Cell Lymphoma is an uncommon type of non-Hodgkin lymphoma that develops in the lymph nodes before building up in the mantle zone, which can then spread into the blood and lymphatic system.
Despite the sad news, The Wildhearts went on to add that the frontman is currently “in fine fettle” and continuing to write music for the band’s upcoming new album, as well as future solo projects.
On top of this, the statement insisted that all planned shows they have for this year will be going ahead, with more to be announced in the coming months along with a follow-up to their 2025 record, The Satanic Rites.
The band rounded out their post by saying: “While we process this news and await further medical advice, Ginger wants everyone to know that strength and positivity will prevail and the show WILL go on.”
They added: “Make sure you come and see The Wildhearts – sounding bigger and more refreshingly amazing than ever – at a venue near you soon.”
The Wildhearts are shortly set to head out on a spring tour of the UK, visiting Liverpool, Portsmouth, Towerbridge, and London in April, before heading to Hull, Aberdeen, Dundee, Stirling, and Edinburgh in May.
Never Miss A Beat
The Far Out Music Newsletter
All the latest music news from the independent voice of culture.
Straight to your inbox.